Sexual function in women with Cushing's Syndrome: A controlled study

Area of Science:

• Endocrinology
• Reproductive Health
• Clinical Medicine

Background:

• Cushing's syndrome (CS) is a rare endocrine disorder characterized by prolonged exposure to excessive cortisol.
• Female sexual dysfunction (FSD) is a multifactorial condition affecting women's quality of life.
• The impact of CS on female sexual function, quality of life, and depression remains incompletely understood.

Purpose of the Study:

• To assess the prevalence and severity of FSD in women with CS.
• To evaluate the quality of life and depression status in female CS patients.
• To explore potential correlations between hormonal profiles and sexual dysfunction in CS.

Main Methods:

• A case-control study involving 29 women with CS and 30 healthy controls.
• Utilized Female Sexual Function Index (FSFI), Beck Depression Inventory (BDI), and SF-36 for assessments.
• Measured plasma levels of reproductive hormones (FSH, LH, PRL, estradiol, testosterone, DHEA-S) and cortisol.

Main Results:

• FSD was diagnosed in 88.9% of women with CS versus 24.1% in controls (p<0.001).
• CS patients reported significantly lower FSFI scores, reduced quality of life (SF-36), and higher depression (BDI) scores.
• CS patients exhibited lower LH, estradiol, and DHEA-S, alongside higher cortisol and 17-hydroxyprogesterone levels compared to controls.

Conclusions:

• The majority of women with Cushing's syndrome experience significant female sexual dysfunction.
• FSD in CS may be linked to the suppressive effects of hypercortisolism on sex hormone production.
• CS negatively impacts women's sexual health, psychological well-being, and overall quality of life.